Ceftiofur
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (6R,7R)-7-[ [(2Z)-2-(2-Amino-1,3-thiazol-4-yl)- 2-methoxyiminoacetyl]amino]-3-(furan-2- carbonylsulfanylmethyl)-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 80370-57-6 |
| ATCvet code | QJ01DD90 QJ51DD90 |
| PubChem | CID 6328657 |
| ChemSpider | 4886668 |
| UNII | 83JL932I1C |
| KEGG | D07657 |
| ChEMBL | CHEMBL222913 |
| Chemical data | |
| Formula | C19H17N5O7S3 |
| Mol. mass | 523.56 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Ceftiofur is an antibiotic of the cephalosporin type (third generation), licensed for use in veterinary medicine. It was first described in 1987.[1] It is marketed by pharmaceutical company Pfizer as Excede.[2]
It is resistant to the antibiotic resistance enzyme beta-lactamase, and has activity against Gram-positive and Gram-negative bacteria. E. coli strains resistant to ceftiofur have been reported.[3]
[edit] References
- ^ Yancey RJ, Kinney ML, Roberts BJ, Goodenough KR, Hamel JC, Ford CW (1987). "Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in mice". Am. J. Vet. Res. 48 (7): 1050–3. PMID 3631686.
- ^ "Pfizer Animal Health Dairy Information on Products and Solutions". http://www.pfizerah.com/index_species.asp?species=DA&country=US&lang=EN. Retrieved 2007-11-20.
- ^ Donaldson SC, Straley BA, Hegde NV, Sawant AA, DebRoy C, Jayarao BM (2006). "Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves". Appl. Environ. Microbiol. 72 (6): 3940–8. doi:10.1128/AEM.02770-05. PMC 1489609. PMID 16751500. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1489609.
[edit] External links
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |